HIV infection from occupational and nonoccupational exposures can be prevented through risk assessment and management with antiretroviral drug therapy (ART). This study sought to examine the pattern of presentation and outcome of clients who were given postexposure prophylaxis (PEP) at the University College Hospital, Ibadan, Nigeria. A retrospective review of case notes of clients presenting for HIV PEP from January 2005 to December 2006 was carried out. A total of 48 clients with a mean age of 27.9 + 12.3 years underwent PEP during the period under review. Rape constituted 50% of reasons for PEP, while needle pricks and blood splash into mucous membranes constituted 25% each. Among those who received therapy, 10 (23.8%) could not complete drug therapy because of side effects. Although no client was HIV positive after the recommended 6 months of follow-up, 8 (16.7%) clients did not complete attendance to the clinic during the period.
Introduction
HIV is the virus that causes AIDS. It can be transmitted from one person to another through exposure to blood or body fluids that contain the virus. Such fluids that contain the virus include blood, semen, vaginal fluid, human breast milk, amniotic fluid, cerebrospinal fluid, pericardial fluid, peritoneal fluid, pleural fluid, synovial fluid, and exudative or other tissue fluid from burns or skin lesions. 1 Other body fluids such as sweat, tears, saliva, urine, and stool do not contain significant quantities of HIV, unless there is blood mixed with them. 1, 2 The principal risks of acquiring HIV infection are through unprotected sexual contact, mother-to-child transmission (including breast feeding), and percutaneous, through exposure of disrupted skin to an infected person's blood. 3 In the work environment, health care workers (HCWs) may be occupationally exposed to HIV infection. Although occupational transmission to HCWs has been documented for blood and visibly bloody fluids, the risk of acquiring HIV infection following occupational exposure to HIV-infected blood is low. 2 In addition, epidemiological studies have indicated that the average risk of HIV infection after percutaneous exposure to HIV-infected blood in health care settings is about 0.3%. However, it is estimated that the risk of HIV transmission after percutaneous exposure involving larger volumes of blood, particularly, if the source patient's viral load is high, exceeds the average risk of 0.3%. 2, 3 After a mucocutaneous exposure, the average risk is estimated at less than 0.1%. There is, however, no risk of HIV transmission, where intact skin is exposed to HIV-infected blood. 2 Despite these varying levels of risk of HIV transmission postexposure management is recommended for all workers who are exposed to blood and body fluids in occupational settings. 1 Although no large prospective randomized controlled trials have been performed to determine the efficacy of immediate administration of antiretroviral (ARV) drugs in preventing infection from occurring, a case-control study in HCWs who have had needlestick exposures has shown that postexposure treatment with ARV drugs can reduce the risk by 79%. 4 To guide physicians in the care of clients requiring postexposure prophylaxis (PEP), the Federal Ministry of Health (FMOH), Nigeria, developed a protocol. 5 The protocol classified exposure to potentially infectious body fluids as low or high risk. Low risk includes solid needle superficial exposure on intact skin; small volume blood on a mucous membrane; asymptomatic source; or viral load <1500 copies/mL. High-risk exposure includes a large bore needle, deep injury, visible blood on a device, needle in patient artery or vein; large volume blood on a mucous membrane; or symptomatic source, acute seroconversion, high viral load.
The protocol prescribed that immediately after the exposure, all exposed individuals should take PEP according to the assumed risk. Those with low risk should take a 2-drug combination and those with high risk should take a 3-drug combination. Where the risk cannot be ascertained, the 2-drug combination should be used. The chosen regimen is continued for 28 days or until the results of HIV tests for the patient and exposed health worker are known to be negative. Recommended schedule of investigations following exposure are as follows: Investigations done at baseline should include full blood count, liver function tests, renal function tests, and HIV screening. Investigations done at 2 weeks include full blood count, liver function tests, and renal function tests. At 6 weeks, and at 3 and 6 months, investigation should include HIV screening. In case of sexual abuse or rape, it is recommended that the victim be counseled for PEP, if the victim is negative. It is important to check the HIV status of the perpetrator if possible. If this is impossible, the perpetrator is assumed to be HIV positive and the victim treated as a case of high-risk exposure. Clients are discharged at the 6-month follow-up, if they remain HIV negative. At anytime during the 6 months, if they are found to be HIV positive, they are managed accordingly. The impact of these guidelines on the care of HIV-exposed clients in Nigeria is not known. This study is, therefore, necessary to determine the pattern of presentation and outcome of PEP applied to clients using the FMOH protocol at the University College Hospital, Ibadan.
Methods
The study was conducted at the Antiretroviral Clinic of the University College Hospital, Ibadan, Nigeria. This clinic was 1 of 25 other ARV clinics established and funded by the federal government in 2002 to provide ARV drugs to an initial 10 000 adults nationwide at a subsidized rate. Since 2004, the president's Emergency Plan for AIDS Relief (PEPFAR) had provided support for the scale-up of the nation's antiretroviral treatment (ART) program. The treatment is provided free to patients since January 2006. The ARV clinic opens daily from 8:00 AM to 5:00 PM, Monday through Thursday. 6 However, the ARV clinic staff attend to emergencies and PEP clients at times at odd hours such as weekends to start highly active antiretroviral therapy (HAART) within the mandatory 72 hours after exposure. The clinic serves the entire southwestern part of Nigeria and beyond.
A retrospective review was carried out of case notes of clients presenting for HIV PEP from January 2005 to December 2006 was carried out. Data retrieved from the clinic records included age, sex and occupation of clients, reasons for PEP, and outcome of follow-up. All clients underwent risk assessment and were managed according to the FMOH HIV PEP protocol. 5 Data were entered and analyzed with Statistical Package for the Social Sciences (SPSS) v 11. Summary statistics using mean and standard deviation for continuous variable and frequency/percentages for categorical variables were generated.
Results
A total of 48 clients underwent PEP during the period under review. The mean age was 27.9 + 12.3 years. Six (12.5%) were <15 years. Thirty-six (75%) were females, while 24 (50%) were health workers, 15 (31.3%) students, and 9 (18.8%) civil servants. Health workers included 8 (16.7%) medical doctors, 12 (25%) nurses, and 4 (8.3%) ward attendants ( Table 1 ). All clients reported and were attended to within 72 hours after their exposures. Table 2 shows that rape constituted 50% of reason for PEP, with needle pricks and blood splash into the mucous membranes constituting 25% each. All the sexually assaulted victims were females and were between 5 and 30 years of age. Half the health workers became exposed through unsafe injection practices; recapping a dirty needle (6), putting up an intravenous line (2), during surgery (1), and during needle disposal (3). None of the clients was HIV positive before commencing PEP. Table 3 shows that the majority 27 (56.3%) had nonnucleoside reverse transcriptase inhibitor (NNRTI)-based HAART, while 12 (25%) had protease inhibitor (PI)-based HAART. Three (6.3%) had Combivir, while 6 (12.5%) had no drug prescribed as they had no risk of HIV exposure because their source of exposure was HIV negative. Table 4 shows that 
Discussion
The level of awareness of HIV/AIDS, its mode of transmission, and availability of prevention and treatment had increased in nearly every Nigerian community since the establishment of ARV clinics nationwide in 2002. 5, 6 This study describes HIV PEP use among a series of clients who presented to 1 of the ARV clinics in Nigeria, following occupational and nonoccupational exposures. The management of PEP clients in the clinic was guided by the protocol developed by the FMOH. 5 Rape was the main nonoccupational exposure indication for PEP in this study. A study on HIV PEP provided at an urban pediatric emergency department identified 56% female adolescents who had suffered forced vaginal intercourse. 7 About onethird of the clients in our series were children and adolescents who were sexually abused. Babl et al showed that PEP in children and adolescents presents a medical and management challenge and requires a coordinated effort at the initial presentation to the health care system and at follow-up. 8 There is the need to carry the caregiver along throughout. Furthermore, all efforts should be made to trace the source of exposure if possible and protect the child privacy. A pediatrician and child psychologist if available could help in these cases. Moreover, availability of drug formulation such as syrups will ensure adherence to therapy as tablets might not be acceptable and might not come in adaptable doses for children.
Although occupational exposure to HIV in a hospital setting presents a low but potential risk of infection, the occupational exposure indications for PEP in this study were needlestick injuries and blood splash into the mucous membrane. The occurrence of these indicates a need for the adoption of standard universal precaution guidelines in our environment as most exposures in HCWs result from breaches of universal precaution. This includes the provision of adequate sharp containers, training of workers in the risks and prevention of transmission of blood-borne viruses, and the use of personal protective equipment such as gloves and eye wear, together with the more recent use of safer devices such as needles that sheath or retract after use. 9 Reid reported that increase in clinical prevalence of AIDS implies an increase in unsafe medical injections. 10 In addition, though PEP were prescribed in accordance with FMOH protocol, 5 23.8% of clients did not complete the treatment due to side effects. These clients, however, reported for follow-up despite the refusal to accept to continue the drugs or change of drugs. Luckily, they remained seronegative. Could this imply that even early exposure to HAART can prevent seroconversion? Studies are needed to confirm or reject this assertion. In a retrospective study of HIV PEP prophylaxis following sexual exposure, low completion rate was attributed to recipients independently clarifying their source's HIV status, poor documentation of adherence, and a high default rate from follow-up. 11 A previous study among health workers in Bangkok, Thailand, reported that only 34% completed the 28-day PEP therapy. 12 This could imply that health workers need to be encouraged to complete therapy to prevent possible development of resistant strains of HIV.
The current study indicated that 12.5% of clients were lost to follow-up. However, among those who were screened for HIV at the sixth month of follow-up, none was positive. This finding is similar to what was reported by Babl et al and Neu et al in the United States, in separate studies, where it was found that none of the 3 of 10 patients in the study by Babl et al and 4 of 7 patients in the study by Nue et al, that reported for followup, was positive. 7, 8 These findings, however, cannot prove or confirm the efficacy of PEP as they are from a case series without control groups. Even prospective clinical trials would require enrolling thousands of clients, given the low rate of HIV seroconversion. The practical, medicolegal, and ethical issues involved in carrying out such trials make it unlikely that they will occur in the future. 9 In conclusion, this study showed that indications for PEP are both occupational and nonoccupational exposures to HIV in our environment. In addition, side effects of treatment are common; hence, the need to warn and reassure clients on the likelihood of their occurrence and reversibility to improve adherence and follow-up. As in previously reported case series, none of the clients who completed the follow-up period developed HIV.
Declaration of Conflicting Interests

